| __timestamp | Amicus Therapeutics, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 31354781 |
| Thursday, January 1, 2015 | 76943000 | 43445817 |
| Friday, January 1, 2016 | 104793000 | 66489820 |
| Sunday, January 1, 2017 | 149310000 | 96886134 |
| Monday, January 1, 2018 | 270902000 | 153793000 |
| Tuesday, January 1, 2019 | 286378000 | 148369000 |
| Wednesday, January 1, 2020 | 308443000 | 151934000 |
| Friday, January 1, 2021 | 272049000 | 198532000 |
| Saturday, January 1, 2022 | 276677000 | 112128000 |
| Sunday, January 1, 2023 | 152381000 | 76192000 |
Unleashing the power of data
In the ever-evolving world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, TG Therapeutics, Inc. and Amicus Therapeutics, Inc. have demonstrated distinct strategies in their R&D investments.
From 2014 to 2023, Amicus Therapeutics consistently increased its R&D budget, peaking in 2020 with a 547% increase from its 2014 spending. This upward trend underscores Amicus's dedication to advancing its therapeutic pipeline. Meanwhile, TG Therapeutics showed a more varied pattern, with a notable 532% rise in R&D expenses from 2014 to 2021, reflecting its strategic focus on developing breakthrough treatments.
These spending patterns highlight the dynamic nature of biotech investments, where strategic R&D allocation can be the key to unlocking future growth and innovation.
Comparing Innovation Spending: Eli Lilly and Company and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and Amicus Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Genmab A/S vs TG Therapeutics, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amicus Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and TG Therapeutics, Inc.
TG Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc.
Viking Therapeutics, Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Amicus Therapeutics, Inc. vs HUTCHMED (China) Limited
Analyzing R&D Budgets: Amicus Therapeutics, Inc. vs Mesoblast Limited